{"schema_version":"alpha-profile-public-v1","slug":"melissa-epperly","canonical_url":"https://registry.alpha.ac/people/melissa-epperly","as_of":"2026-09-22T02:43:42.262417+00:00","published_at":"2026-09-02T02:37:22.247177+00:00","last_reviewed_at":"2026-05-16T01:20:49.346+00:00","identity":{"display_name":"Melissa Epperly","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive","board"],"current_role":{"company_name":"Roivant Sciences Ltd.","company_slug":"roivant-sciences-ltd","exchange":"NASDAQ","ticker":"ROIV","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2022-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125027846/ny20049997x1_def14a.htm","effective_date":"2025-07-29","last_checked_at":"2026-04-29T02:10:01.477+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=melissa-epperly","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=melissa-epperly&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Melissa Epperly served as Chief Financial Officer of Zentalis Pharmaceuticals and PsiOxus Therapeutics, leading financial operations and business development. She has extensive experience in life sciences financing, having previously worked at Goldman Sachs, Bain Company, and Morgan Stanley, and currently serves on the board of Roivant Sciences Ltd."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Roivant Sciences Ltd.","organizationId":"roivant-sciences-ltd","title":"Director","period":"2022-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125027846/ny20049997x1_def14a.htm"},{"organization":"Nautilus Biotechnology, Inc.","organizationId":"nautilus-biotechnology-inc","title":"Director","period":"2021-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1808805/000180880525000043/nautilusdef14a20250620a.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Roivant Sciences Ltd.","company_slug":"roivant-sciences-ltd","exchange":"NASDAQ","ticker":"ROIV","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2022-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125027846/ny20049997x1_def14a.htm","effective_date":"2025-07-29","last_checked_at":"2026-04-29T02:10:01.477+00:00"}},{"company_name":"Nautilus Biotechnology, Inc.","company_slug":"nautilus-biotechnology-inc","exchange":"NASDAQ","ticker":"NAUT","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2021-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880525000043/nautilusdef14a20250620a.htm","effective_date":"2025-04-29","last_checked_at":"2026-04-28T23:38:01.221+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Melissa Epperly as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:20:49.581409+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NAUT DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880525000043/nautilusdef14a20250620a.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-16T01:20:49.420263+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_membership","claim_value":{"ticker":"ROIV","role_type":"Director","organization":"Roivant Sciences"},"claim_text":"Serves on the board of Roivant Sciences as Director.","claim_state":"verified","valid_from":"2022-01-01","valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:42.619055+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Roivant Sciences director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125027846/ny20049997x1_def14a.htm","published_at":"2025-07-29T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:44.926776+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Melissa Epperly currently serves as Director at Roivant Sciences.","claim_state":"verified","valid_from":"2025-07-29","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-06T06:25:50.540097+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ROIV DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125027846/ny20049997x1_def14a.htm","published_at":"2025-07-29T00:00:00+00:00","last_checked_at":"2026-05-06T06:25:50.467738+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Melissa Epperly currently serves as Director at Nautilus Biotechnology, Inc..","claim_state":"verified","valid_from":"2025-04-29","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:20:49.532835+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NAUT DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880525000043/nautilusdef14a20250620a.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-16T01:20:49.420263+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Audit"],"claim_text":"Melissa Epperly serves on Audit.","claim_state":"verified","valid_from":"2025-07-29","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-06T06:25:50.558902+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ROIV DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125027846/ny20049997x1_def14a.htm","published_at":"2025-07-29T00:00:00+00:00","last_checked_at":"2026-05-06T06:25:50.467738+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Audit","Nominating/Governance"],"claim_text":"Melissa Epperly serves on Audit, Nominating/Governance.","claim_state":"verified","valid_from":"2025-04-29","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:20:49.556644+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NAUT DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880525000043/nautilusdef14a20250620a.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-16T01:20:49.420263+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":{"committees":["Audit"]},"claim_text":"Committee assignments at Roivant Sciences: Audit.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:42.619055+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Roivant Sciences director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125027846/ny20049997x1_def14a.htm","published_at":"2025-07-29T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:44.926776+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"Tenpoint Therapeutics, Ltd.","claim_text":"Melissa Epperly is linked to Tenpoint Therapeutics, Ltd. as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-06T06:25:50.763628+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ROIV DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125027846/ny20049997x1_def14a.htm","published_at":"2025-07-29T00:00:00+00:00","last_checked_at":"2026-05-06T06:25:50.467738+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"Chief Financial Officer","claim_text":"Melissa Epperly is also listed as Chief Financial Officer.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-06T06:25:50.743942+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ROIV DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125027846/ny20049997x1_def14a.htm","published_at":"2025-07-29T00:00:00+00:00","last_checked_at":"2026-05-06T06:25:50.467738+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Melissa Epperly as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:20:49.634086+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NAUT DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880525000043/nautilusdef14a20250620a.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-16T01:20:49.420263+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"director_since","claim_value":{"start_date":null,"director_since":2022},"claim_text":"Director tenure at Roivant Sciences begins from 2022.","claim_state":"verified","valid_from":"2022-01-01","valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:42.619055+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Roivant Sciences director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125027846/ny20049997x1_def14a.htm","published_at":"2025-07-29T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:44.926776+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"independence_status","claim_value":{"is_independent":true},"claim_text":"Board independence status at Roivant Sciences: True.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:42.619055+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Roivant Sciences director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125027846/ny20049997x1_def14a.htm","published_at":"2025-07-29T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:44.926776+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Melissa Epperly as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:20:49.611827+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NAUT DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880525000043/nautilusdef14a20250620a.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-16T01:20:49.420263+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:melissa-epperly","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2022-01-01 · current","organization":"Roivant Sciences Ltd.","organization_id":"roivant-sciences-ltd"},"claim_text":"Director at Roivant Sciences Ltd. (2022-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125027846/ny20049997x1_def14a.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1},{"subject":"alpha:person:melissa-epperly","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2021-01-01 · current","organization":"Nautilus Biotechnology, Inc.","organization_id":"nautilus-biotechnology-inc"},"claim_text":"Director at Nautilus Biotechnology, Inc. (2021-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880525000043/nautilusdef14a20250620a.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/melissa-epperly#profile","url":"https://registry.alpha.ac/people/melissa-epperly","dateModified":"2026-05-16T01:20:49.346+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/melissa-epperly#person","name":"Melissa Epperly","url":"https://registry.alpha.ac/people/melissa-epperly","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Roivant Sciences Ltd.","tickerSymbol":"NASDAQ: ROIV"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2022-01-01","memberOf":{"@type":"Organization","name":"Roivant Sciences Ltd.","url":"https://registry.alpha.ac/companies/roivant-sciences-ltd","tickerSymbol":"NASDAQ: ROIV"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2021-01-01","memberOf":{"@type":"Organization","name":"Nautilus Biotechnology, Inc.","url":"https://registry.alpha.ac/companies/nautilus-biotechnology-inc","tickerSymbol":"NASDAQ: NAUT"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880525000043/nautilusdef14a20250620a.htm","name":"NAUT DEF 14A director slate"},{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125027846/ny20049997x1_def14a.htm","name":"Roivant Sciences director board source"}],"mainEntityOfPage":"https://registry.alpha.ac/people/melissa-epperly"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":11,"corroborated":3,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":14,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":7,"distinct_source_count":2,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":11,"corroborated":3,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":14,"corroborated_claims":3,"sources":7,"distinct_sources":2,"role_claims":2,"last_reviewed_at":"2026-05-16T01:20:49.346+00:00","observed_at":"2026-09-22T02:43:42.262417+00:00","freshness_days":129}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"melissa-epperly","canonical_url":"https://registry.alpha.ac/people/melissa-epperly"},"publication":{"published_at":"2026-09-02T02:37:22.247177+00:00","last_reviewed_at":"2026-05-16T01:20:49.346+00:00","as_of":"2026-09-22T02:43:42.262417+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/melissa-epperly","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/melissa-epperly","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/melissa-epperly.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}